Next 10 |
Pfizer (NYSE:PFE) confirmed that the HSR waiting period for its planned purchase of Arena Pharmaceuticals (NASDAQ:ARNA) expired on Wednesday. The $6.7B acquisition of Arena (ARNA) is now expected to close on Friday, according to an 8-K filing. The confirmation comes after a report o...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded at a new 52-week high today of $99.95. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Arena Pharmaceuticals is a biotechnology company targeting G-protein-couple...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks had a so-so year in 2021, as the Covid-19-induced boost the sector received in the previous year wore off. The iShares Biotechnology ETF (NASDAQ: IBB ), which is considered a proxy for the sector, gaine...
Arena Pharmaceuticals (NASDAQ:ARNA) rose 1.1% in after hours trading after a Nasdaq delisting notice indicated the company's last trading day would be Thursday due to the completion of its sale to Pfizer Inc (NYSE:PFE). The merger is tentatively scheduled to close prior to the marke...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $98.57. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares. Over the past year, Arena Pharmaceuticals Inc. has traded in a range of $45...
Arena Pharmaceuticals (NASDAQ:ARNA) rose 3.5% in after hours trading on a report that it's planned sale to Pfizer Inc. (NYSE:PFE) won't require a longer review from the Federal Trade Commission, according a Dealreporter item. The waiting period under the Hart-Scott Rodino ("HSR...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
The outlook for the pharmaceutical and biotech industry is good thanks to resilience versus crises and large macro tailwinds. XBI and many biotech names have sold off a lot over the last year. The ETF is now trading lower than before the pandemic. XBI's approach is different from ...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $95.23. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Arena Pharmaceuticals is a biotechnology company targeting G-protein-couple...
Shares of Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at $94.97, eclipsing its 52-week high. This new high was reached on below average trading volume as 748,000 shares traded hands, while the average 30-day volume is approximately 1.2 million shares. Arena Pharmaceuticals is a...
News, Short Squeeze, Breakout and More Instantly...
Arena Pharmaceuticals Inc. Company Name:
ARNA Stock Symbol:
NASDAQ Market:
Arena Pharmaceuticals Inc. Website:
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded at a new 52-week high today of $99.95. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Arena Pharmaceuticals is a biotechnology company targeting G-protein-couple...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $98.57. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares. Over the past year, Arena Pharmaceuticals Inc. has traded in a range of $45...